Ferrous Sulfate Iron Supplement Drops Recalled for Manufacturing Stability Issues
All lots of Ferrous Sulfate Iron Supplement Drops are being recalled nationwide. The manufacturer went out of business and cannot complete required stability studies to verify product safety.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a precautionary recall due to incomplete manufacturing stability studies caused by firm closure. While FDA classified this as Class II, no illnesses or injuries have been reported, and the hazard remains theoretical pending completion of safety verification studies.
Plain-English summary
Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles and distributed nationwide in the USA and Puerto Rico, are being recalled. The product is manufactured by Akorn, Inc., and all lots are affected.
The recall was issued because the manufacturer went out of business and can no longer continue the stability studies required by FDA regulations. These studies are essential to verify that the product maintains its quality and potency throughout its shelf life.
Consumers who have purchased this product should stop using it and consult with a healthcare provider or pharmacist about alternative iron supplements. Those with questions about the recall should contact the FDA or a healthcare professional.
The recalled product
- Product
- Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Supplement / Iron
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · stability unverified
See all →- HighFluticasone Propionate Nasal Spray Recalled Due to Manufacturing Quality Concerns
FDA (Drugs) · 2023-06-07
- ModerateAkorn Recalls Cromolyn Sodium Ophthalmic Solution Over Stability Studies
FDA (Drugs) · 2023-06-07
- HighTrihexyphenidyl Hydrochloride Oral Solution Recalled for Unverified Stability
FDA (Drugs) · 2023-06-07
- HighNeomycin and Polymyxin B Eye Ointment Recalled for Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighClobetasol Propionate Ointment recalled due to manufacturing compliance failures
FDA (Drugs) · 2023-06-07